USPTO serial 99106752
Reviewed by CopyMark Law Group
The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Plus Government fees of $150
Tirat Carmel, IL
Tirat Carmel, IL
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Julia Anne Matheson
Julia Anne Matheson Potomac Law Group, PLLC1717 Pennsylvania Avenue, NW, Suite 1025Washington, DC 20006United States| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Therapeutic drug delivery agents being compounds containing resonators that facilitate the delivery of pharmaceutical preparations and monitoring thereof for use in connection with medical ultrasound apparatus to facilitate the lowering of the blood brain barrier; Therapeutic drug delivery agents being compounds containing resonators that facilitate the delivery of pharmaceutical preparations and monitoring thereof for use in connection with medical ultrasound apparatus to facilitate the disruption of the blood brain barrier; Therapeutic drug delivery agents being compounds containing resonators that facilitate the delivery of pharmaceutical preparations and monitoring thereof for use in connection with medical ultrasound apparatus to increase the permeability of the blood brain barrier; Therapeutic drug delivery agents being compounds containing resonators that facilitate the delivery of pharmaceutical preparations and monitoring thereof to be used in connection with ultrasound apparatus for therapeutic and diagnostic medical procedures in the fields of neurology, oncology, gynecology and urology; Therapeutic drug delivery agents being compounds containing resonators that facilitate the delivery of pharmaceutical preparations and monitoring thereof to be used in connection with ultrasound apparatus for therapeutic and diagnostic medical procedures with respect to central nervous system disorders, neurodegenerative disease, neuro-oncological disease, neuropsychiatric and behavioral disorders, movement disorders, prostate cancer, uterine fibroids and bone metastases; Therapeutic drug delivery agents being compounds containing resonators that facilitate the delivery of pharmaceutical preparations and monitoring thereof to be used in connection with ultrasound apparatus for therapeutic and diagnostic medical procedures, namely, for use in the ablation of tissue, sonication of tissue, and disruption of the blood brain barrier | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 21, 2026 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Apr 21, 2026 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Apr 21, 2026 | EXT1 | SOU EXTENSION 1 FILED | — |
| Apr 21, 2026 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Dec 16, 2025 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Oct 21, 2025 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 21, 2025 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 15, 2025 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Sep 24, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 24, 2025 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Sep 24, 2025 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Sep 24, 2025 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Sep 24, 2025 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Aug 26, 2025 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 26, 2025 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 26, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 26, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 11, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 27, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Mar 27, 2025 | NWAP | NEW APPLICATION ENTERED | — |